Contact Us
Partnership
Fund Lines
Overview
Team
Contact

contact@hinainvest.com

Home
Overview
Partnership
Fund Lines

HINA: Healthcare Innovation, Novel Approach

HINA, an outsourced investment and innovation partner for Pharma Services & the Life Sciences, supports industry leaders in building market share in priority growth segments

HINA exclusively partners with industry leaders to invest in paradigm-shifting service, tool & software innovators, creating strategic access & strategic insights into focus subsectors

HINA is an innovation & investment partner for Industry Leaders in Healthcare.

HINA creates dedicated fund lines for growth themes, anchored by a single Industry Leader per fund line. Leveraging HINA’s unique stage-agnostic, hyper-specialized approach to investment, HINA builds a portfolio of high-growth service, tool & software providers for each fund line, which in turn creates strategic access & strategic insights for partners in focus growth segments.

A Paradigm Shift in Healthcare Innovation & Investment

Hyper-specialized

HINA is a sub-sector focused investor, targeting select high-growth, high-impact investment themes

Partnership-centric

By partnering with HINA, industry leaders build strategic access & strategic insights with reduced costs & risk

Stage-agnostic

HINA partners with innovators through all stages of development, from inception through growth financing to value realization

Expertise

HINA’s hyper-specialized mandate, supported by our experienced team and advisors, facilitates market-leading insights

Benefits from Partnering with HINA

Stratagic Access & Insights

for Industry Leaders

STRATEGIC ACCESS

Improved access to deals with preferred positioning & lower effective entry price for acquisitions

Reduced conflicts of interest & risk for investments

Better access to arms-length, win-win commercial partnerships

Outsourcing to a growth investment specialist facilitates more effective deal-making for small deals

STRATEGIC INSIGHTS

Access to HINA's proprietary market research & analytics

Access to customer-level decision makers through portfolio company

Detailed portfolio company reporting highlights sub-sector trends

Access to HINA network, including scientifc KOLs, portfolio executives & strategic advisors

More, higher-quality acquistions at lower effective valuations, with stronger commercial partnerships in focus sectors

Access to detailed information facilitates strategic decision making & increased market share for organic growth initiatives

More, higher-quality acquistions at lower effective entery-prices, with increasead sommercial partnerships in focus sectors

List of Services

Acquisition opportunities
- HINA LPs will benefit from earlier access, improved information rights & existing partnership structures in the acquisition of HINA portfolio companies
- As part of customary LP reporting, HINA will grant strategic investors significant information access throughout the sale process for any PortCo
Item Link List Item 1
Commercial partnership opportunities
- HINA LPs will have the opportunity to develop arms-length commercial partnerships
- HINA will facilitate PortCo purchasing of Industry Leader products / services where relevant
- HINA LPs will have priority access to PortCos / decision maker introductions to facilitate collaborations
Item Link List Item 2
Broader access to deal flow
- HINA’s sector-specific structure will facilitate improved deal flow in chosen sectors vs a multi-sector approach
- HINA’s stage-agnostic approach opens up more deal opportunities (incl. buyout, majority / minority, venture (seed through late-stage) & company inception), thus increasing deal flow vs a strict venture approach
Item Link List Item 3
Reduced risk associated with investments
- Investment through HINA allows industry leaders to invest in emerging competitors without antitrust risks
- Investment through HINA enables avoidance of issues associated with board participation & fiduciary duty management with conflicts of interest
- Reduced disclosure of strategic activity to competitors
Item Link List Item 4
Reduced cost / infrastructure through outsourcing
- Outsourcing CVC activity to HINA in select strategies reduces internal hiring & reporting needs, saving costs and improving efficiencies
- Outsourcing external investment in select strategies to HINA reduces inefficiencies created by internal resource constraints & processes (e.g., managing $1Bn and $5M deals simultaneously)
Item Link
Benefit from fund efficiencies & incentives
- Leverage HINA team’s expertise in deal execution
- Improved incentives associated with independent fund ownership vs internal hires (carry etc.)
- Better returns on PortCo companies not acquired by partner, without having a strategic on cap table
- Lower effective deal price from existing ownership
Item Link

Fund Lines

Exclusively focused on large TAM,

high-growth market segments

HINA is open to partnering with Industry Leaders to create thematic funds focused on areas of strategic interest

exclusively focused on large TAM, high-growth market segments.

HINA 1.0

Bioprocessing 4.0

Fully Deployed

Portfolio Companies

HINA 2.0

Bioprocessing 4.0

Ongoing Fundraise

Currently

Fundraising

HINA 3.0

Bioconjugates

Ongoing Fundraise

Currently

Fundraising

Custom Fund

HINA is open to partnering with Industry Leaders to create thematic funds focused on areas of strategic interest

Currently

Fundraising

Team

A Paradigm Shift in Healthcare Innovation & Investment

Digitalization of paper-based bioprocess monitoring & analytical systems, will generate significant savings & drive process optimization, especially for advanced therapies. Digitalization will enable a transition from a component-centric process to an output-centric proces.